These results suggested that FXR overexpression may decrease cholesterol synthesis in human TSGH8301 and T24 bladder cancer cells by reducing SREBP2, HMGCR, and PI3KAKT/mTOR signaling and enhancing AMPK phosphorylation. This evidence concerns the gene NR1H4 and urinary bladder carcinoma.